Acid Paraaminobenzoic PABA
Acid Paraaminobenzoic
PABA
Acid Paraaminobenzoic pentru ingrijirea pielii si a parului
1 Acid Paraaminobenzoic PABA cu actiune sinergica cu cortizon in tratamentul
de artrita reumatoida
2 Acid Paraaminobenzoic PABA face parte din gruba B Complex cu efect clinic
pentru ingrijirea pielii la pigmentatie si fertilitate
3 Stiinta ingrijirii parului: Terapia cu Acid Paraaminobenzoic PABA
inchide culoarea firului de par alb.
4 Acid Paraaminobenzoic PABA si Acidul Pantotenic din gruba B Complex
inchide culoarea firului de par alb la barbati
5 Lumina solara aduce daune pielii
6 Factorul de protectie solara SPF
(Sunscreen Protection Factor) previne foto carcinogeneza indusa de razele ultraviolete
tip A si B
7 Acid Paraaminobenzoic PABA la protectia tenului de razele ultraviolete
care induc tumora de piele si keratoza actinica
Produse-naturale ca: Acid Paraaminobenzoic PABA pentru ingrijirea pielii
8 Acid Paraaminobenzoic PABA cu efect la factorul de protectia solara SPF
(Sunscreen Protection Factor), impotriva ultravioletelor
tip A si B
9 Acid Paraaminobenzoic PABA cu efect de inhibare a melanogenezei si folosirea
la tratamentul cacerului de piele - melanomul
10 Acid Paraaminobenzoic PABA administrata oral la vitiligo
11 Acid Paraaminobenzoic PABA cu raspuns la dermatomiozita si lupus eritematos
sistemic
12 Acid Paraaminobenzoic PABA la tratamentul de lupus eritematos
13 Acid Paraaminobenzoic PABA la terapia de dermatomiozita si scleroderma
14 Acid Paraaminobenzoic PABA in comparatie cu placebo in tratamentul de
scleroderma
15 Acid Paraaminobenzoic PABA ca raspuns la terapia de scleroderma, studiu
retrospectiv
16 Acid Paraaminobenzoic PABA cu efect la scleroderma
17 Terapia de Acid Paraaminobenzoic PABA cu rezultat in tratamentul de scleroderma
18 Acid Paraaminobenzoic PABA cu efect si capacitate vitala la scleroderma,
studiu retrospectiv
19 Acid Paraaminobenzoic PABA la tratamentul de pemfigus
20 Acid Paraaminobenzoic PABA cu protectie de toxicitatea indusa de ozon
Bibliografie - Referinte: Acid Paraaminobenzoic
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1 Wiesel LL, Barritt AS, Stumpe WM. The synergistic action of para-aminobenzoic
acid and cortisone in the treatment of rheumatoid arthritis. Am J Med Sci 1951;222:243–8.
2 Sieve
BF. The clinical effects of a new B complex factor, para-aminobenzoic acid, on
pigmentation and fertility. South Med Surg. 1942;104:135–139.
3 Zarafonetis,
CJ. Darkening of gray hair during para-amino-benzoic acid therapy. J Invest Dermatol.
1950
Dec;15(6):399-401.
- Zvak, C. The Science of Hair Care, 1986, Marcel Dekker, Inc., New York.
4 Brandaleone,
H., Maine, E., and Steele, J.M. The effect of calcium panthothenate and para-aminobenzoic
acid on gray hair in man. Am J Medical Science, 1944,
206: 315.
5 Kligman
AM. Early destructive effect of sunlight on human skin. JAMA. 1969 Dec
29;210(13):2377-80.
6 Kligman
LH, Akin FJ, Kligman AM. Sunscreens prevent ultraviolet photocarcinogenesis.
J Am Acad Dermatol. 1980 Jul;3(1):30-5.
7 Synder
DS, May M. Ability of PABA to protect mammalian skin from ultraviolet light-induced
skin tumors and actinic damage. J Invest Dermatol. 1975 Dec;65(6):543-6.
8 Willis
I, Kligman AM. Aminobenzoic acid and its esters. The quest for more effective
sunscreens. Arch Dermatol. 1970 Oct;102(4):405-17.
9 rooks,
Peter C.; (Carmel, NY); Morais, Danielle; (Bedford Hills, NY); Rodriguez,
Dorothy; (Pequannock, NJ) The present invention relates to the
inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its
use in treating
melanotic cancer.
10 Hughes
CG. Oral PABA and vitiligo. J Am Acad Dermatol 1983;9:770
11 Gaby
AR. The story of PABA. Nutr Healing 1997;March:3–4, 11
12 Zarafonetis
CJD, Grekin RH, Curtis AC, et al. Further studies on the treatment of
lupus erythematosus with sodium para-aminobenzoate. J Invest
Dermatol 1948;11:359.
13 Grace
WJ et al. Therapy of scleroderma and dermatomyositis. NY State J Med
1963;63:140-144.
14 Clegg
DO, Reading JC, Mayes MD. Comparison of aminobenzoate potassium and placebo
in the treatment of scleroderma. J Rheumatol. 1994;21:105–110.
15 Zarafonetis
CJ, Dabich L, Skovronski JJ, et al. Retrospective studies in scleroderma:
skin response to potassium para-aminobenzoate therapy. Clin Exp
Rheumatol.
1988;6:261–268.
16 Zarafonetis
CJ, Dabich L, Negri D, et al. Retrospective studies in scleroderma: effect
of potassium para-aminobenzoate on survival. J Clin Epidemiol. 1988;41:193–205.
17 Zarafonetis
CJD. The treatment of scleroderma: results of potassium para-aminobenzoate
therapy in 104 cases. In: Mills LC, Moyer JH eds. Inflammation and Diseases
of Connective Tissue. Philadelphia: W. B. Saunders Co. 1961, 688–96.
18 Zarafonetis
CJ, Dabich L, Devol EB, et al. Retrospective studies in scleroderma: pulmonary
findings and effect of potassium p-aminobenzoate on vital capacity.
Respiration 1989;56:22–33.
19 Zarafonetis
CJD, Curtis AC, Shaw JM. Treatment of pemphigus with potassium para-aminobenzoate.
Am J Med Sci 1956;231:30–50.
20 Goldstein,
et al. PABA as a protective agent in ozone toxicity. Arch Environ Health.
24:243-247, 1972.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
1 Fl. Acid Paraaminobenzoic PABA o substanta vitala pentru par cu o concentratie eficienta de 100 ori respectiv 500 mg 30 buc.
